Drug profile · INN
osimertinib mesilate
TAGRISSO
osimertinib mesilate (TAGRISSO) is a epidermal growth factor receptor erbb1 inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 21
News articles 0
Drug details — osimertinib mesilate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 21
- Data quality
- 0.78
Quick answer
osimertinib mesilate (TAGRISSO) is a epidermal growth factor receptor erbb1 inhibitor.
Key facts
INN osimertinib mesilate
Brand TAGRISSO
Mechanism Epidermal growth factor receptor erbB1 inhibitor
Target Epidermal growth factor receptor
Mechanism of action
Epidermal growth factor receptor erbB1 inhibitor
Primary target: Epidermal growth factor receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is osimertinib mesilate?
osimertinib mesilate (TAGRISSO) is a epidermal growth factor receptor erbb1 inhibitor.
What is the brand name for osimertinib mesilate?
TAGRISSO is a marketed brand name for osimertinib mesilate. Check FDA Drugs@FDA for the current US label holder and prescribing information.